New diabetes clinical trial: Study of Liver Fibrosis Stage Assessment by TEP Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
Published on: December 06, 2023 at 11:00PM
Conditions: Non-alcoholic Steatohepatitis
Interventions: Drug: PET scan of 68Ga-FAPI
Sponsors: Central Hospital, Nancy, France
Not yet recruiting
https://ift.tt/dMK8sZ5
Conditions: Non-alcoholic Steatohepatitis
Interventions: Drug: PET scan of 68Ga-FAPI
Sponsors: Central Hospital, Nancy, France
Not yet recruiting
https://ift.tt/dMK8sZ5
Comments
Post a Comment